공지사항

[BPS] COVID-19 변이 바이러스 연구용 kit (SAR-CoV-2 research)

작성일 2021-05-06 · 조회 2207


 

 

BPS bioscience사에서는 다양한 COVID-19 연구 제품들을 판매하고 있습니다.

특이 이번에 B.1.1.7(UK), B.1.351 (South African), P.1 (Brazilian) strain, 변이 종들에 대한 특이적인 assay 제품들이 준비되었습니다. 

cat.no.ProductsizeApplication
78109RdRp (SARS-CoV-2) Homogeneous Assay Kit384 rxnsGreat for studying enzyme kinetics and HTS applications.
78133Spike RBD (B.1.1.7 Variant) (N501Y) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit96 rxnsThis kit is useful for screening for inhibitors of ACE2 binding to SARS-CoV-2 Spike RBD UK variant (N501Y).
78140Spike RBD (B.1.1.7 Variant) (N501Y) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit96 rxnsThis kit is useful for screening for inhibitors of ACE2 binding to SARS-CoV-2 Spike RBD UK variant (N501Y).
78154Spike S1 (B.1.1.7 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit96 rxnsThis kit is useful for screening for inhibitors of ACE2 binding to SARS-CoV-2 Spike S1 B.1.1.7 Variant.
78155Spike S1 (B.1.1.7 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit96 rxnsThis kit is useful for screening for inhibitors of ACE2 binding to SARS-CoV-2 Spike S1 B.1.1.7 variant.
78151Spike S1 RBD (B.1.351 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Chemiluminescence Assay Kit96 rxnsThis kit is useful for screening inhibitors of ACE2 binding to Spike S1 RBD-B.1.351 (SARS-CoV-2).
78152Spike S1 RBD (B.1.351 Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit96 rxnsThis kit is useful for screening inhibitors of ACE2 binding to Spike S1 RBD-B.1.351 (SARS-CoV-2).

 

그리고 unique한 새로운 antibody가 준비되어 있습니다.

 

Spike S1 Neutralizing Antibody (WT, B.1.1.7 and B.1.351 Variant) (Clone C-A11) (SARS-CoV-2) #101024

 

이 외에도 변이종에 대한 특이 antibody, kit, lentivirus 등이 준비되어 있습니다.

Coronavirus 카달로그 

 

위 제품들에 세부 문의사항이 있으시다면 (주)동인바이오텍 (T. 02-431-7375) 학술팀으로 연락주시기 바랍니다. 

첨부파일 BPS_Coronavirus-2.pdf
▲ 다음글 [ALPCO] Catecholamines ELISA kit 2021-05-21
▼ 이전글 [Bethyl] Immuno-oncology 2021-04-22
TOP